Stay updated on IBI310 Combo vs Sorafenib in HCC Clinical Trial
Sign up to get notified when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.

Latest updates to the IBI310 Combo vs Sorafenib in HCC Clinical Trial page
- CheckyesterdayChange DetectedThe site footer now identifies the release as v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check8 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1, with no apparent change to the study record.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedThe record history now reflects a new revision entry v3.7.0 and the removal of the older v3.6.6 entry, indicating an update to the study record’s version history.SummaryDifference0.1%

- Check49 days agoChange DetectedThe study record history now includes a new revision entry v3.6.6 and removes the previous v3.6.5, reflecting an update to the official history log.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision entry v3.6.5 was added to the Record History and the previous v3.6.4 entry was removed, reflecting a version update to the study record.SummaryDifference0.1%

- Check85 days agoChange DetectedThe study record history now shows a new release entry, Revision: v3.6.4, replacing the prior Revision: v3.6.3. This is a non-content update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to IBI310 Combo vs Sorafenib in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.